MariMed Inc. provided earning guidance for the full year 2024. For the year, the company's financial targets remain at: revenue growth of 5% to 7%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 USD | +4.94% | -9.09% | -38.14% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.14% | 64.66M | |
+6.32% | 2.74B | |
+47.67% | 516M | |
-15.91% | 391M | |
+30.99% | 165M | |
-1.11% | 96.55M | |
+40.45% | 56.99M |
- Stock Market
- Equities
- MRMD Stock
- News MariMed Inc.
- MariMed Inc. Provides Earning Guidance for the Full Year 2024